
WB analysis of whole cell extracts (20 microg lysate) of A431 (Lane 1) treated for 1 hr with 100 uM of Pervanadate (Lane 2), HeLa (Lane 3) treated for 20 minutes with 50 ng/ml of TNF alpha (lane 4), NIH/3T3 (Lane 5) treated for 10 minutes with 50 ng/ml of PDGF (Lane 6), A549 (Lane 7) treated for 20 minutes with 200 nM of PMA (Lane 8) using GTX24832 Paxillin (phospho Tyr31) antibody. Dilution : 1:500-1:2000
Paxillin (phospho Tyr31) antibody
GTX24832
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
Product group Antibodies
TargetPXN
Overview
- SupplierGeneTex
- Product NamePaxillin (phospho Tyr31) antibody - Orthogonal Validated
- Delivery Days Customer9
- Application Supplier NoteICC/IF: 1:250. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID5829
- Target namePXN
- Target descriptionpaxillin
- Target synonymspaxillin; testicular tissue protein Li 134
- HostRabbit
- IsotypeIgG
- Protein IDP49023
- Protein NamePaxillin
- Scientific DescriptionThis gene encodes a cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion). Alternatively spliced transcript variants encoding different isoforms have been described for this gene. These isoforms exhibit different expression pattern, and have different biochemical, as well as physiological properties (PMID:9054445). [provided by RefSeq, Aug 2011]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin. Metalli D et al., 2010 Jun, Am J PatholRead more